A Randomized, Phase II Study of Nimotuzumab Plus Gefitinib vs Gefitinib in Advanced Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy
JOURNAL OF THORACIC ONCOLOGY（2015）
Key words
non-small cell lung cancer,EGFR,gefitinib,EGFR monoclonal antibody
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined